Abstract
Given the current financial climate there is an ever increasing need to substitute drug treatments to optimize expenditure. A closer examination of the beliefs surrounding when substitution is appropriate led a group of European healthcare experts to argue that in some cases these beliefs may be unfounded and that guidelines are needed for clinical practice.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have